These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23424731)

  • 21. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What we know about influenza vaccine and Guillain-Barré syndrome.
    Enos L
    Oreg Nurse; 2009 Nov; ():5. PubMed ID: 19998739
    [No Abstract]   [Full Text] [Related]  

  • 23. Global Advisory Committee on Vaccine Safety, 16-17 December 2002.
    Wkly Epidemiol Rec; 2003 Jan; 78(4):17-20. PubMed ID: 12585021
    [No Abstract]   [Full Text] [Related]  

  • 24. Global Advisory Committee on Vaccine Safety, 6–7 December 2017.
    Wkly Epidemiol Rec; 2018 Jan; 93(2):17-30. PubMed ID: 29350500
    [No Abstract]   [Full Text] [Related]  

  • 25. Guillain-Barré syndrome associated with H1N1 vaccination.
    Marin LF; Abrahão A; Carvalho FA; Santos WA; Dallalba CC; Barcelos LB; Silva GS; Oliveira AS
    Arq Neuropsiquiatr; 2010 Dec; 68(6):974-5. PubMed ID: 21243265
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety of influenza vaccination: Risk-benefit evaluation.
    Wiwanitkit V
    Muscle Nerve; 2010 Aug; 42(2):296; author reply 296. PubMed ID: 20544931
    [No Abstract]   [Full Text] [Related]  

  • 27. [Guillain-Barré syndrome secondary to H1N1 influenza vaccine].
    López Nieto M; Gómez Garrido J; Losa Palacios A; Aguila Manso G
    Rev Clin Esp; 2010 Oct; 210(9):485-6. PubMed ID: 20832792
    [No Abstract]   [Full Text] [Related]  

  • 28. Global Advisory Committee on Vaccine Safety, 3–4 December 2014.
    Wkly Epidemiol Rec; 2015 Jan; 90(4):17-24. PubMed ID: 25618910
    [No Abstract]   [Full Text] [Related]  

  • 29. H1N1 vaccine safety monitoring: beyond background rates.
    Destefano F; Tokars J
    Lancet; 2010 Apr; 375(9721):1146-7. PubMed ID: 19880171
    [No Abstract]   [Full Text] [Related]  

  • 30. Recurrent Guillain-Barre syndrome following vaccination.
    Baxter R; Lewis N; Bakshi N; Vellozzi C; Klein NP;
    Clin Infect Dis; 2012 Mar; 54(6):800-4. PubMed ID: 22267712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guillain-Barré syndrome and influenza vaccines: current evidence.
    Sanz Fadrique R; Martín Arias L; Molina-Guarneros JA; Jimeno Bulnes N; García Ortega P
    Rev Esp Quimioter; 2019 Aug; 32(4):288-295. PubMed ID: 31232571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.
    Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR
    Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].
    Press R; Andersen O
    Lakartidningen; 2010 Mar 10-16; 107(10):666-7. PubMed ID: 20402249
    [No Abstract]   [Full Text] [Related]  

  • 34. Hospital discharge data for Guillain-Barré syndrome and influenza A (H1N1) vaccine adverse events.
    Jones TF; McMillian M; Boothe E; Hanna S; Ingram LA
    Emerg Infect Dis; 2010 Sep; 16(9):1500-1. PubMed ID: 20735949
    [No Abstract]   [Full Text] [Related]  

  • 35. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
    Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
    Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
    Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza vaccines and guillain-barre syndrome: the continuing question.
    Sejvar JJ
    Neurology; 2013 Oct; 81(18):1562-3. PubMed ID: 24166961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meeting of the Global Advisory Committee on Vaccine Safety,June 2011.
    Wkly Epidemiol Rec; 2011 Jul; 86(30):321-4. PubMed ID: 21800467
    [No Abstract]   [Full Text] [Related]  

  • 39. Lack of antibody response to Guillain-Barré syndrome-related gangliosides in mice and men after novel flu vaccination.
    Yuki N; Takahashi Y; Ihara T; Ito S; Nakajima T; Funakoshi K; Furukawa K; Kobayashi K; Odaka M
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):116-7. PubMed ID: 21084265
    [No Abstract]   [Full Text] [Related]  

  • 40. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
    Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
    Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.